Live feed
Filing
SC 13G
SC 13G0000921895-23-000654·ASLAN Pharmaceuticals Ltd
Schedule 13G ownership disclosure
ASLAN PHARMACEUTICALS LTD
Security class unavailable · CUSIP: 04522R101
Event date: 2023-02-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-23-000654
- Form type
- SC 13G
- Filer
- ASLAN Pharmaceuticals Ltd
- CIK
- CIK 1722926
- Filed
- Mar 06, 2023
- Reporting period
- Feb 24, 2023
- Description
- Schedule 13G beneficial ownership